1.
This Act may be cited as the
Flu Protection Act of
2005
.
<enum>I</enum>
<header>Flu vaccine awareness campaign</header>
<section commented="no" display-inline="no-display-inline" id="IDE93B46DE8F2E47A79F224A424CFDB9E2" section-type="subsequent-section">
<enum>101.</enum>
<header>Awareness campaign and education and outreach efforts</header>
<text display-inline="no-display-inline">Part P of title III of the
<act-name parsable-cite="PHSA">Public Health Service Act</act-name>
(<external-xref legal-doc="usc" parsable-cite="usc/42/300aa-1">42 U.S.C.
280g</external-xref> et seq.) is amended by adding at the end the
following:</text>
<quoted-block act-name="Public Health Service Act" display-inline="no-display-inline" id="ID4F0DFBBB2262436DAE9DA95553864DE2" style="OLC">
<section commented="no" display-inline="no-display-inline" id="IDD36456B8C90548A98024196C6F075691" section-type="subsequent-section">
<enum>399O.</enum>
<header>Awareness campaign and education and outreach
efforts</header>
<subsection commented="no" display-inline="no-display-inline" id="id318D5363224D42B4ADC9DAA4A9F9039F">
<enum>(a)</enum>
<header>Campaign</header>
<text display-inline="yes-display-inline">The Secretary, acting
through the Director of the Centers for Disease Control and Prevention (in this
section referred to as the <quote>Director</quote>), shall conduct a public
awareness campaign and education and outreach efforts each year during the time
period preceding the influenza season on each of the following:</text>
<paragraph commented="no" display-inline="no-display-inline" id="IDAE63FAB435524805B003B6C2E0EAE186">
<enum>(1)</enum>
<text display-inline="yes-display-inline">The importance of receiving
the influenza vaccine.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID385CEABD377E454F82D056FA8BA0668A">
<enum>(2)</enum>
<text display-inline="yes-display-inline">Which populations the
Director recommends to receive the influenza vaccine to prevent health
complications associated with influenza, including health care workers and
household contacts.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDFA710567628E40FA843FC0CA2E658524">
<enum>(3)</enum>
<text display-inline="yes-display-inline">Professional medical
education of physicians, nurses, pharmacists, and other health care providers
and such providers’ associated organizations.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDF6753D03FE2D4536A40B7F1E7A4BE4A5">
<enum>(4)</enum>
<text display-inline="yes-display-inline">Information that emphasizes
the safety and benefit of recommended vaccines for the public good.</text>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID6CE219BE91454E4895DBB20BB744B6BC">
<enum>(b)</enum>
<header>Outreach to Medicare recipients</header>
<paragraph commented="no" display-inline="no-display-inline" id="IDDEFB09C230DD4768A5C25501A9CAD1C5">
<enum>(1)</enum>
<header>In general</header>
<text display-inline="yes-display-inline">The Administrator of the
Centers for Medicare & Medicaid Services shall, at the earliest possible
time in the influenza vaccine planning and production process, reach out to
providers of medicare services, including managed care providers, nursing
homes, hospitals, and physician offices to urge early and full preordering of
the influenza vaccine so that production levels can accommodate the needs for
the influenza vaccine.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDD43405FB3D0D4A4B9D41617CE830223A">
<enum>(2)</enum>
<header>Rates of immunization among Medicare recipients</header>
<text display-inline="yes-display-inline">The Director shall work
with the Administrator of the Centers for Medicare & Medicaid Services to
publish the rates of influenza immunization among individuals receiving
assistance under the medicare program under title XVIII of the
<act-name parsable-cite="SSA">Social Security Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395">42 U.S.C. 1395</external-xref> et
seq.).</text>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID2BFBF245FC8F49F29467E20BD541986D">
<enum>(c)</enum>
<header>State and public health adult immunization
activities</header>
<text display-inline="yes-display-inline">The Director shall support
the development of State adult immunization programs that place emphasis on
improving influenza vaccine delivery to high-risk populations and the general
population, including the exploration of improving access to the influenza
vaccine.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="ID19354206AA0B4236B4973393CFA3EE29">
<enum>(d)</enum>
<header>Efficacy of vaccine</header>
<text display-inline="yes-display-inline">The Director shall work
with appropriate agencies in conducting a study to assess the efficacy of the
influenza vaccine.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="ID4F8E572F6703488291A64185D68076C6">
<enum>(e)</enum>
<header>Existing modes of communication</header>
<text display-inline="yes-display-inline">In carrying out the public
awareness campaign and education and outreach efforts under subsections (a) and
(b), the Director may use existing websites or structures for
communication.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="ID42F7D09CCE7944B09D3B7F914E2BCCE7">
<enum>(f)</enum>
<header>Authorization of appropriations</header>
<text display-inline="yes-display-inline">There are authorized to be
appropriated to carry out this section $10,000,000 for each of fiscal years
2005 through 2009.</text>
</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
</section>
<enum>II</enum>
<header>Encouraging vaccine production capacity</header>
<section commented="no" display-inline="no-display-inline" id="IDA88CB61BBD96459887C39FF56822992F" section-type="subsequent-section">
<enum>201.</enum>
<header>Incentives for the construction of vaccine manufacturing
facilities</header>
<subsection commented="no" display-inline="no-display-inline" id="ID0CB43128F8574DAF954FB47AAC8CDFCC">
<enum>(a)</enum>
<header>Vaccine manufacturing facilities investment tax credit</header>
<paragraph commented="no" display-inline="no-display-inline" id="ID3AD6F69862CD40A986AB64F351B359BF">
<enum>(1)</enum>
<header>Allowance of credit</header>
<text display-inline="yes-display-inline">Section 46 of the Internal
Revenue Code of 1986 (relating to amount of investment credit) is amended by
striking <quote>and</quote> at the end of paragraph (1), by striking the period
at the end of paragraph (2) and inserting <quote>, and</quote>, and by adding
at the end the following new paragraph:</text>
<quoted-block display-inline="no-display-inline" id="IDD6C29ED15CA1430E94F4A17575871443" style="OLC">
<paragraph commented="no" display-inline="no-display-inline" id="ID38C68C0DC2134BB79F9D435B3828F4EF">
<enum>(3)</enum>
<text display-inline="yes-display-inline">the vaccine manufacturing
facilities investment credit.</text>
</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDC3B538A5A2834379809E1CCD489FB763">
<enum>(2)</enum>
<header>Amount of credit</header>
<text display-inline="yes-display-inline">Subpart E of part IV of
subchapter A of chapter 1 of such Code (relating to rules for computing
investment credit) is amended by inserting after section 48 the following new
section:</text>
<quoted-block display-inline="no-display-inline" id="ID6EFCF331DEBD4D188AA43072F036CF97" style="OLC">
<section commented="no" display-inline="no-display-inline" id="ID4F187A6627564B19B4C22F8E276326C5" section-type="subsequent-section">
<enum>48A.</enum>
<header>Vaccine manufacturing facilities credit</header>
<subsection commented="no" display-inline="no-display-inline" id="IDF05E788269AF4425890EA0D960308678">
<enum>(a)</enum>
<header>In general</header>
<text display-inline="yes-display-inline">For purposes of section 46,
the vaccine manufacturing facilities investment credit for any taxable year is
an amount equal to 20 percent of the qualified investment for such taxable
year.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="ID67A42EEBB7B846CEAE27ABC409C142C9">
<enum>(b)</enum>
<header>Qualified investment</header>
<paragraph commented="no" display-inline="no-display-inline" id="id6155240C4935415D85602374838EFCD7">
<enum>(1)</enum>
<header>In general</header>
<text display-inline="yes-display-inline">For purposes of subsection
(a), the qualified investment for any taxable year is the basis of each vaccine
manufacturing facilities property placed in service by the taxpayer during such
taxable year.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID81773A73B4694571A7AB373483A28AF1">
<enum>(2)</enum>
<header>Vaccine manufacturing facilities property</header>
<text display-inline="yes-display-inline">For purposes of this
section, the term <term>vaccine manufacturing facilities property</term> means
real and tangible personal property—</text>
<subparagraph commented="no" display-inline="no-display-inline" id="ID40E873CDB65C47F19D95A1D865B33B2A">
<enum>(A)</enum>
<clause commented="no" display-inline="yes-display-inline" id="ID6D15FC78D1B84F269570F3E1938BEF30"><enum>(i)</enum>
<text display-inline="yes-display-inline">the original use of which
commences with the taxpayer, or</text>
</clause><clause commented="no" display-inline="no-display-inline" id="IDBD341A6E08E5460B9FE657E1D6BAC367" indent="up1">
<enum>(ii)</enum>
<text display-inline="yes-display-inline">which is acquired through
purchase (as defined by section 179(d)(2)),</text>
</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDBF67CABCFB1E4BB0A8DF34F821F9343F">
<enum>(B)</enum>
<text display-inline="yes-display-inline">which is depreciable under
section 167,</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID033DB817BAE64D08A42E7E23909B98D5">
<enum>(C)</enum>
<text display-inline="yes-display-inline">which is used for the
manufacture, distribution, or research and development of vaccines, and</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDDF92B2110F59491E8E370D60B1EB57F3">
<enum>(D)</enum>
<text display-inline="yes-display-inline">which is in compliance with
any standards and regulations which are promulgated by the Food and Drug
Administration, the Occupational Safety and Health Administration, or the
Environmental Protection Agency and which are applicable to such
property.</text>
</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDC4CB3070845749A4BD505D14365E74EE">
<enum>(c)</enum>
<header>Certain progress expenditure rules made applicable</header>
<text display-inline="yes-display-inline">Rules similar to rules of
subsections (c)(4) and (d) of section 46 (as in effect on the day before the
date of the enactment of the Revenue Reconciliation Act of 1990) shall apply
for purposes of this subsection.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="IDDC328C3A5D28421C86B045E0CC0C373B">
<enum>(d)</enum>
<header>Termination</header>
<text display-inline="yes-display-inline">This subsection shall not
apply to any property placed in service after December 31, 2009.</text>
</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID96D7EF87616B422A80AAD8B9C196DD27">
<enum>(b)</enum>
<header>Technical amendments</header>
<paragraph commented="no" display-inline="no-display-inline" id="IDAA2BE3A0B10A4541A11AA89851C71899">
<enum>(1)</enum>
<text display-inline="yes-display-inline">Clause (iii) of section
49(a)(1)(C) of such Code is amended to read as follows:</text>
<quoted-block display-inline="no-display-inline" id="ID481B207AC92B4407A70EE7AB5A1F05C0" style="OLC">
<clause commented="no" display-inline="no-display-inline" id="ID3412D185AFE74DA9B701448DBB7FEEDB">
<enum>(iii)</enum>
<text display-inline="yes-display-inline">the basis of any vaccine
manufacturing facilities property.</text>
</clause><after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID1B6706CDEE8B4E799382B89EE1061EA4">
<enum>(2)</enum>
<text display-inline="yes-display-inline">Subparagraph (E) of section
50(a)(2) of such Code is amended by inserting <quote>or 48A(c)</quote> before
the period.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="idCEBA2D9511534F91B3886EADBCFF309D">
<enum>(3)</enum>
<text display-inline="yes-display-inline">The table of sections for
subpart E of part IV of subchapter A of chapter 1 of such Code is amended by
inserting after the item relating to section 48 the following:</text>
<quoted-block display-inline="no-display-inline" id="IDD26C206CBBD5495DAD0CC8E61E56A8A2" style="USC">
<toc regeneration="no-regeneration">
<toc-entry bold="off" level="section">Sec. 48A. Vaccine manufacturing
facilities
credit.</toc-entry>
</toc>
<after-quoted-block>.</after-quoted-block></quoted-block>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID0238720740FE4CFBB8FE594850040E22">
<enum>(c)</enum>
<header>Effective date</header>
<text display-inline="yes-display-inline">The amendments made by this
section shall apply to property placed in service after December 31, 2004,
under rules similar to the rules of section 48(m) of the Internal Revenue Code
of 1986 (as in effect on the day before the date of enactment of the Revenue
Reconciliation Act of 1990).</text>
</subsection></section>
<enum>III</enum>
<header>Ensuring sufficient flu vaccine supply</header>
<section commented="no" display-inline="no-display-inline" id="ID3482CDD12C134008B2E15D4F4B932D32" section-type="subsequent-section">
<enum>301.</enum>
<header>Vaccine supply</header>
<text display-inline="no-display-inline">Title XXI of the
<act-name parsable-cite="PHSA">Public Health Service Act</act-name> (42 U.S.C.
300aa–1 et seq.) is amended by adding at the end the following:</text>
<quoted-block act-name="" display-inline="no-display-inline" id="ID1A2B68EA329F431385A249A0E426EF53" style="traditional">
<subtitle commented="no" id="id6ED88ADAE4514601A5C952965D3E1502" style="traditional">
<enum>3</enum>
<header>Influenza Vaccine</header>
<section commented="no" display-inline="no-display-inline" id="ID943AFEF4C2C3426986CE1C76C4C75691" section-type="subsequent-section">
<enum>2141.</enum>
<header>Vaccine supply</header><subsection commented="no" display-inline="yes-display-inline" id="IDA64DB36E381741BF800BE61957531A1D"><enum>(a)</enum>
<header>Requests for more doses</header>
<paragraph commented="no" display-inline="no-display-inline" id="ID6EB704A4799C4774B3A886FFB91E5024">
<enum>(1)</enum>
<header>In general</header>
<text display-inline="yes-display-inline">Not later than March 15 of
each year, the Secretary shall enter into contracts with manufacturers to
produce such additional doses of the influenza vaccine as determined necessary
by the Secretary.</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID91BBC5707C454449A91F62C9C398D73E">
<enum>(2)</enum>
<header>Content of contract</header>
<text display-inline="yes-display-inline">A contract for additional
doses shall provide that the manufacturer will be compensated by the Secretary
at an equitable rate negotiated by the Secretary and the manufacturer for any
doses that—</text>
<subparagraph commented="no" display-inline="no-display-inline" id="IDCFA11588D8E842199B0EBB2B14FD811C">
<enum>(A)</enum>
<text display-inline="yes-display-inline">were not sold by the
manufacturer through routine market mechanisms at the end of the influenza
season for that year; and</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID7253051FE774462E94ED04003A619D23">
<enum>(B)</enum>
<text display-inline="yes-display-inline">were requested by the
Secretary to be produced by such manufacturer.</text>
</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID8B3B5395D2124130B6EE0C9B744EA184">
<enum>(3)</enum>
<header>When such vaccine purchases should take place</header>
<text display-inline="yes-display-inline">The Secretary may purchase
from the manufacturer the doses for which it has contracted at any time after
which it is determined by the Secretary, in consultation with the manufacturer,
that the doses will likely not be absorbed by the private market.</text>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDBBA7807C69254B44BAF84A90CFB8540E">
<enum>(b)</enum>
<header>Contingency plan</header>
<text display-inline="yes-display-inline">The Secretary shall
encourage States to develop a contingency plan, in coordination with the
Department of Health and Human Services, for maximizing influenza immunization
for high-risk populations in the event of a delay or shortage of the influenza
vaccine.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="IDC2D9278C84844873AF24458186642B77">
<enum>(c)</enum>
<header>Authorization of appropriations</header>
<text display-inline="yes-display-inline">There are authorized to be
appropriated to carry out this section such sums as may be necessary.</text>
</subsection></section></subtitle><after-quoted-block>.</after-quoted-block></quoted-block>
</section>
<enum>IV</enum>
<header>Preparing for a pandemic or epidemic</header>
<section commented="no" display-inline="no-display-inline" id="ID087C6C3F28394EEB9D35ABA99AE1F5A0" section-type="subsequent-section">
<enum>401.</enum>
<header>Preparation for influenza pandemic or epidemic</header>
<text display-inline="no-display-inline">Subtitle 3 of title XXI of the
<act-name parsable-cite="PHSA">Public Health Service Act</act-name>, as added
by section 301, is amended by adding at the end the following:</text>
<quoted-block act-name="Public Health Service Act" display-inline="no-display-inline" id="IDE4993E75BF8F40F397F7644B1E2F8D7D" style="traditional">
<section commented="no" display-inline="no-display-inline" id="ID8AEB830E228E4BF5AD8F0F5ACAE20B00" section-type="subsequent-section">
<enum>2142.</enum>
<header>Preparation for influenza pandemic or
epidemic</header><subsection commented="no" display-inline="yes-display-inline" id="ID784B63639CA64B0BAFE6A5D35FD31DCF"><enum>(a)</enum>
<header>Establishment of a protocol</header>
<text display-inline="yes-display-inline">The Secretary, acting
through the Director of the National Vaccine Program (referred to in this
section as the <quote>Director of the Program</quote>), shall continue progress
on the pandemic preparedness plan and, in consultation with the Director of the
Centers for Disease Control and Prevention, establish a protocol to attempt to
prevent, prepare for, and respond to an influenza pandemic or epidemic. Such
protocol shall be updated as determined appropriate by the Director of the
Program.</text>
</subsection><subsection commented="no" display-inline="no-display-inline" id="IDE1A8B09CD5BD48C9B606BED4E69B749A">
<enum>(b)</enum>
<header>Contents of protocol</header>
<text display-inline="yes-display-inline">The protocol established
under subsection (a) shall—</text>
<paragraph commented="no" display-inline="no-display-inline" id="ID2FAFB20E3404462E885BB6308F671D2D">
<enum>(1)</enum>
<text display-inline="yes-display-inline">improve upon the current
influenza vaccines and production and dissemination methods; and</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID0D577DFACD544854BD6BF36D94C75594">
<enum>(2)</enum>
<text display-inline="yes-display-inline">address—</text>
<subparagraph commented="no" display-inline="no-display-inline" id="idC701D5683BAA41808F7A12741A18FFEE">
<enum>(A)</enum>
<text display-inline="yes-display-inline">methods to coordinate
dissemination of the influenza vaccine to key populations in the event of an
influenza pandemic or epidemic;</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID6E47F5EC124E4BC591C3528040A279F6">
<enum>(B)</enum>
<text display-inline="yes-display-inline">expansion of influenza
vaccine manufacturing capacity (including making advance arrangements for
ensuring the availability of raw materials) to respond to the needs of the
United States during an influenza pandemic or epidemic;</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID1BB89ADDF75A468E9C5C59785A8724C4">
<enum>(C)</enum>
<text display-inline="yes-display-inline">alternative ways to
manufacture or produce the influenza vaccine;</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID328E7D2CC1A246EF8410E47462B5BFCE">
<enum>(D)</enum>
<text display-inline="yes-display-inline">alternative methods to
prevent the spread of, and complications associated with, influenza, including
antiviral medications;</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id2027739055E44D3FA2E996CB60FA8AB5">
<enum>(E)</enum>
<text display-inline="yes-display-inline">vaccine manufacturing
capacity, production, and dissemination to improve preparedness for immediate
pandemic threats, which may include avian influenza;</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDD814952307E0484AB07F8C0E41E4F50E">
<enum>(F)</enum>
<text display-inline="yes-display-inline">a tracking method for
publicly and privately sold doses of the influenza vaccine to enable the
Director of the Program to determine, after consultation with manufacturers of
the influenza vaccine, how much supply is in circulation in the case of an
influenza pandemic or epidemic; and</text>
</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID54F276521F1542E9BA890C7C5C84CE1F">
<enum>(G)</enum>
<text display-inline="yes-display-inline">other issues determined by
the Director of the Program to be appropriate.</text>
</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID0EF9BE4E70C24CB78D27507335DEABE0">
<enum>(c)</enum>
<header>Coordination; preparation; prevention</header>
<text display-inline="yes-display-inline">In establishing the
protocol under subsection (a), the Director of the Program shall—</text>
<paragraph commented="no" display-inline="no-display-inline" id="ID838288E5D1C14852855CF07B0DBF2A88">
<enum>(1)</enum>
<text display-inline="yes-display-inline">coordinate with health care
providers, manufacturers, research institutions, health care organizations, and
other expert stakeholders;</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="id8D0C82517A784EAAB9788730F6F85E6D">
<enum>(2)</enum>
<text display-inline="yes-display-inline">continue building
international and national surveillance capacity;</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="id04C2C9A360D24BCB9F7DCFD7FD10557E">
<enum>(3)</enum>
<text display-inline="yes-display-inline">continue to engage in
epidemiological studies and research on novel influenza viruses; and</text>
</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDCF57EB1E896647AFAA0BDCFD3819AB4C">
<enum>(4)</enum>
<text display-inline="yes-display-inline">assist States with
preparedness activities for a rapid State and local response to an influenza
pandemic, including exploring methods of making the influenza vaccine more
accessible to the general population.</text>
</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDEFB84DE4F5B4468F846E362697AAC535">
<enum>(d)</enum>
<header>Authorization of appropriations</header>
<text display-inline="yes-display-inline">There are authorized to be
appropriated to carry out this section $150,000,000 for each of fiscal years
2005 through 2009.</text>
</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
</section>